Adria Molero Valenzuela I am a pre-doctoral researcher in the research group Childhood Cancer and Hematological Diseases and specifically I work on the development of RNA-based therapies for the treatment of Hepatoblastoma, the most common liver tumor in children and adolescents. Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Adria Molero Valenzuela LinkedIn Twitter Orcid Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca I am a pre-doctoral researcher in the research group Childhood Cancer and Hematological Diseases and specifically I work on the development of RNA-based therapies for the treatment of Hepatoblastoma, the most common liver tumor in children and adolescents.
I graduated in Biology at the University of Barcelona (UB) doing my final thesis at the Department of Hereditary Cancer of IDIBELL and then I did my master's degree in Biomedicine, also at the UB, where I did my final thesis at the Laboratory of Molecular Biology in Cancer of the Faculty of Medicine of Bellvitge. Currently, I am starting my PhD in Biochemistry, Molecular Biology and Biomedicine.
Projects Targeting chromatin remodelers for cancer therapy IP: Miguel Segura Ginard Collaborators: Targeting chromatin remodelers for cancer therapy, Marta Miera Maluenda, Adria Molero Valenzuela, Lucas Moreno Martín-Retortillo Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 150000 Reference: 2024 PROD 00054 Duration: 02/12/2024 - 01/06/2026 Development of prognostic and therapeutic tools targeting epigenetic regulators in metastatic neuroblastoma IP: Miguel Segura Ginard Collaborators: Development of prognostic and therapeutic tools targeting epigenetic regulators in metastatic neuroblastoma, Development of prognostic and therapeutic tools targeting epigenetic regulators in metastatic neuroblastoma, Lorena Valero Arrese, Adria Molero Valenzuela, Khloud Abdo Soliman Elsharawy Funding agency: Instituto de Salud Carlos III Funding: 315000 Reference: PI23/01144 Duration: 01/01/2024 - 31/12/2026 Desenvolupament de fàrmacs per inhibir la funció del complexe remodelador de la cromatina BAF. IP: Miguel Segura Ginard Collaborators: Adria Molero Valenzuela Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 20000 Reference: 2021 LLAV 00002 Duration: 12/10/2022 - 11/07/2023 Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders IP: Lucas Moreno Martín-Retortillo Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 00638 Duration: 01/01/2022 - 30/06/2025
